PPAR-α has been demonstrated to be involved in fatty acid metabolism in various tissues, including the liver, and the activation of PPAR-α leads to significant improvements in hepatic steatosis and inflammation in NAFLD [66]. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.